Biotoxtech Co Stock EBITDA
| 086040 Stock | KRW 5,600 50.00 0.88% |
Biotoxtech Co fundamentals help investors to digest information that contributes to Biotoxtech's financial success or failures. It also enables traders to predict the movement of Biotoxtech Stock. The fundamental analysis module provides a way to measure Biotoxtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotoxtech stock.
Biotoxtech |
Biotoxtech Co Company EBITDA Analysis
Biotoxtech's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Biotoxtech EBITDA | 5.67 B |
Most of Biotoxtech's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Biotoxtech Co reported earnings before interest,tax, depreciation and amortization of 5.67 B. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The ebitda for all Republic of Korea stocks is notably lower than that of the firm.
Biotoxtech EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotoxtech's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotoxtech could also be used in its relative valuation, which is a method of valuing Biotoxtech by comparing valuation metrics of similar companies.Biotoxtech is currently under evaluation in ebitda category among related companies.
Biotoxtech Fundamentals
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Shares Owned By Insiders | 26.95 % | |||
| Shares Owned By Institutions | 0.68 % | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| Gross Profit | 6.4 B | |||
| EBITDA | 5.67 B | |||
| Net Income | 6.98 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Target Price | 15000.0 | |||
| Beta | 0.84 | |||
| Market Capitalization | 115.73 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Working Capital | (4.75 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
| Z Score | 34.2 | |||
| Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |